Skip to main content
. 2017 Apr 3;10:1947–1954. doi: 10.2147/OTT.S123042

Table 2.

The correlation between clinicopathologic characteristics and serum CTSB or serum CysC

Characteristic n CTSB
CysC
CysC/CTSB
Mean ± SD P-value Mean ± SD P-value Mean ± SD P-value
Age (years) 0.412a 0.428a 0.510a
 ≥58.5 28 39.17±2.51 725.34±9.19 18.59±2.65
 <58.5 28 37.44±3.26 681.55±13.39 18.08±1.89
Gender 0.341a 0.212a 0.635a
 Male 31 39.46±2.34 733.89±11.81 18.55±2.71
 Female 25 37.24±4.51 673.61±8.67 17.66±1.94
Pathologic type 0.631a 0.621a 0.378a
 SCC 50 38.13±2.61 701.44±16.62 18.42±2.46
 ADC 6 39.65±3.64 723.74±13.74 18.22±2.07
Grade 0.459b 0.771b 0.169b
 G1 11 37.57±6.98 702.34±13.69 18.71±2.39
 G2 25 39.36±2.99 716.35±9.00 18.18±2.28
 G3 20 38.32±5.21 688.98±12.33 18.10±1.88
T status 0.008a 0.459a 0.001a
 T1 + T2 24 29.35±3.38 693.18±14.62 22.57±2.73
 T3 + T4 32 45.12±4.56 711.40±9.88 16.28±1.87
Lymph node metastasis 0.871a 0.239a 0.001a
 No 20 38.81±4.71 729.14±8.32 19.36±2.28
 Yes 36 38.17±2.86 687.58±11.89 15.28±1.64

Notes:

a

Mann–Whitney U test,

b

Kruskal–Wallis test.

Abbreviations: ADC, adenocarcinoma; CTSB, cathepsin B; CysC, cystatin C; IQ, interquartile; SCC, squamous cell carcinoma; SD, standard deviation.